Agilent Technologies specializes in providing application-focused solutions within the life sciences, diagnostics, and applied chemical markets globally. The company operates through three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers a variety of analytical instruments, including chromatography systems and mass spectrometry equipment, alongside laboratory automation and analytical software. The Diagnostics and Genomics segment focuses on advanced genetic analysis tools, including DNA mutation detection and gene expression profiling, as well as quality control solutions for nucleic acid samples. The Agilent CrossLab segment supplies laboratory consumables, custom chemistries, and a range of support services aimed at optimizing laboratory operations. With a strong customer base across biopharmaceutical, environmental, academic, and government sectors, Agilent Technologies emphasizes collaboration and innovation to address evolving scientific needs. Headquartered in Santa Clara, California, the company utilizes multiple sales channels, including direct sales and electronic commerce, to reach its diverse clientele.
Nicoya Lifesciences Inc. develops sensor products to get affinity, kinetics, and specificity for proteins, antibodies, DNA, RNA, enzymes, polymers, and small molecules. The company offers surface plasmon resonance (SPR) instruments, spectrophotometers, sensor chips, SPR reagents and kits, and SPR accessories; and OpenSPR, a personal label-free biomolecular analysis instrument. It also provides software solutions, such as TraceDrawer, a real-time kinetic analysis software; OpenSPR software that allows the control of the OpenSPR instrument and real time data acquisition; and OpenSpec, a software program for real time optical peak tracking. The company was founded in 2012 and is based in Kitchener, Canada.
Akadeum Life Sciences, Inc. is a life sciences company headquartered in Ann Arbor, Michigan, that specializes in manufacturing microbubble cell separation products. Founded in 2014, the company focuses on isolating mammalian and bacterial cells from complex mixtures, offering a range of products including T cell and B cell isolation kits for human and mouse cells. Additionally, Akadeum provides depletion microbubbles for red blood cell removal and streptavidin microbubbles for targeting and capturing various biological entities. Its innovative approach utilizes buoyancy-activated cell sorting, which employs microscopic microbubbles to effectively isolate target cells by floating them to the surface of liquid samples. These advancements enable medical practitioners to perform downstream testing and analysis with enhanced efficiency. The company sells its products online and has established a strategic partnership with Agilent Technologies.
RareCyte, Inc. is a life sciences company based in Seattle, Washington, that specializes in the development of liquid and tissue biopsy analysis platforms aimed at the detection of rare cells. Founded in 2009, RareCyte focuses on providing innovative technologies for the Life Sciences research, drug development, and diagnostic markets. The company offers a range of products, including sample preparation systems, staining kits, and automated fluorescence microscopy instruments. Its AccuCyte system is particularly notable for enabling the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. RareCyte's technologies are designed to address complex challenges in cancer and cardiovascular disease research, facilitating advancements in precision medicine and non-invasive prenatal testing.
MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.
MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.
MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.
BioTek Instruments, Inc. specializes in the development, manufacturing, and sale of life science instrumentation and software. The company offers a diverse range of products, including multi-mode microplate readers, imaging and microscopy systems, and liquid handling instruments such as microplate washers, dispensers, and pipetting systems. BioTek also provides automation solutions, including robotic microplate stackers, as well as data analysis software and accessories for laboratory applications. Its instruments support various fields, including healthcare, pharmaceuticals, agriculture, and research, facilitating cost-effective analysis and quantification of biomolecules and cellular functions. Headquartered in Winooski, Vermont, BioTek has a global presence with offices and support services in multiple countries, including Germany, China, and the United Kingdom. Founded in 1968, the company operates as a subsidiary of Agilent Technologies, Inc. since 2019.
Mission Bio, Inc. specializes in tools for studying cellular heterogeneity in human health and life science research. The company utilizes microfluidic droplet technology to provide solutions for molecular analysis at the single-cell level. Its flagship product, the Tapestri Platform, is the first single-cell multi-omics platform, allowing for the simultaneous detection of genotype and phenotype from the same cell, which enhances the understanding of disease progression and treatment responses. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating targeted single-cell DNA custom panels, applicable in various fields including oncology, blood cancers, solid tumors, and genome editing validation. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.
Genohm SA is a developer of cloud-based software solutions focused on laboratory management, founded in 2002 and headquartered in Lausanne, Switzerland. The company specializes in software automation solutions that integrate Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), and order management. Genohm's SLims platform is designed to allow scientists to customize their digital data management systems according to individual laboratory workflows. The company's client base includes a diverse range of international organizations, such as biobanks, research and development laboratories, next-generation sequencing laboratories in universities and hospitals, and biotechnology companies. Since May 2018, Genohm has operated as a subsidiary of Agilent Technologies, Inc.
LaserGen, Inc. is a biotechnology company based in Houston, Texas, founded in 2002. It specializes in developing and commercializing nucleotides and tools that cater to life science solutions, particularly in the fields of next-generation sequencing and histology. The company creates technologies designed to detect heritable and somatic sequence variations in the human genome, which serve as diagnostic tools for disease management. By focusing on innovative chemistry, LaserGen aims to provide scientists with cost-effective and accurate platforms for DNA sequencing and other genomics applications. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.
Luxcel Biosciences Ltd., founded in 2002 and based in Cork, Ireland, specializes in porphyrin-based, phosphorescent oxygen-sensing probes and sensors. The company primarily serves the pharmaceutical, food safety, and packaging industries, providing a range of products including oxygen and pH sensors, as well as assays for mitochondrial function, metabolism, and toxicity. Notable offerings include the MitoXpress–Xtra assay for measuring oxygen consumption, the pH-Xtra assay for monitoring extracellular acidification, and the MitoXpress-Intra assay for assessing cell oxygenation. Luxcel also offers the OpTech system for non-invasive package integrity and shelf-life studies, alongside rapid microbial tests for bacterial detection. The company's tools are utilized in diverse applications such as cell analysis, hepatotoxicity, and food safety testing. Luxcel Biosciences sells its products directly and through authorized distributors, catering to pharmaceutical companies, processed food manufacturers, biotechnology firms, university labs, and research institutes.
NanoCellect Biomedical, Inc. develops innovative flow cytometry and cell sorting technology aimed at enhancing the capabilities of life science researchers in cellular analysis, molecular diagnostics, and personalized medicine. Founded in 2009 and based in San Diego, California, the company offers the WOLF Cell Sorter, which utilizes a closed fluid-path microfluidic cartridge to facilitate cell sorting while minimizing biohazard risks and shear stress commonly associated with traditional methods. By making flow cytometry more affordable and accessible, NanoCellect aims to support biomedical researchers in analyzing and isolating cells efficiently, thereby promoting significant advancements in drug discovery and diagnostics. The company's technology is designed to provide rapid, objective, and quantitative data on individual cells, empowering scientists to conduct essential research with greater ease and precision.
LaserGen, Inc. is a biotechnology company based in Houston, Texas, founded in 2002. It specializes in developing and commercializing nucleotides and tools that cater to life science solutions, particularly in the fields of next-generation sequencing and histology. The company creates technologies designed to detect heritable and somatic sequence variations in the human genome, which serve as diagnostic tools for disease management. By focusing on innovative chemistry, LaserGen aims to provide scientists with cost-effective and accurate platforms for DNA sequencing and other genomics applications. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.
Seahorse Bioscience specializes in the development of analytical instruments, biomanufacturing systems, and consumable labware for biological research and drug discovery. The company's flagship products include the Seahorse Extracellular Flux (XF) analyzers, which enable scientists to non-invasively measure the metabolic activity of cells. These instruments provide valuable insights into various cellular processes, including basal oxygen consumption, glycolysis rates, ATP turnover, and respiratory capacity, facilitating research into mitochondrial dysfunction. Seahorse Bioscience serves a diverse clientele, including academic institutions, pharmaceutical and biotech companies, as well as OEM manufacturers of assay kits and laboratory instruments.
BioSystem Development specializes in creating, manufacturing, and marketing system products aimed at addressing unmet needs in biotechnology and life science research. The company's innovative offerings include cartridges filled with small polymer beads, which facilitate rapid protein analysis for drug developers. By focusing on these specific applications, BioSystem Development supports advancements in research and enhances the efficiency of biotechnological processes.
Lab901
Acquisition in 2011
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.
Biocius Life Sciences, Inc. is a company specializing in drug discovery research, established in 2009 and located in Woburn, Massachusetts. As a subsidiary of BioTrove, Inc., Biocius develops advanced technologies, including high-throughput mass spectrometry systems, to facilitate the drug discovery process. The company's innovative approach aims to enhance efficiency and accuracy in identifying potential therapeutic compounds, contributing to advancements in pharmaceutical research and development.
Stratagene Corporation develops, manufactures, and markets life science research products in the United States and internationally. The company supports advances in science by inventing, manufacturing, and distributing products that simplify, accelerate, and improve research. Its products are used in the academic, industrial, and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery, and toxicology.
SynPro
Acquisition in 2006
SynPro Corp. manufactures short synthetic DNA and RNA molecules for the pharmaceutical and biotech industries. Its products are used as components of drugs in clinical trials. It makes synthetic nucleic acids used in biotech research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.